A nursing student asks the nurse why more is not known about the teratogenic effects of maternal medication ingestion during pregnancy. Which response by the nurse is correct?
“Clinical trials to assess this risk would put the fetus at risk.”
“The relatively new FDA study will allow testing of medications during pregnancy in the future.”
“Most women are reluctant to admit taking medications while they are pregnant.”
“It is safer to recommend that pregnant women avoid medications while pregnant.”
The Correct Answer is A
Choice A Reason:
Clinical trials to assess the teratogenic effects of medications during pregnancy are ethically challenging because they would involve exposing pregnant women and their fetuses to potential risks. The primary concern is the safety of the fetus, as many drugs can cross the placenta and potentially cause harm. Therefore, most of the data on teratogenic effects come from observational studies, case reports, and animal studies rather than controlled clinical trials.
Choice B Reason:
While the FDA has initiatives to improve the safety of medications during pregnancy, it is not accurate to say that a new study will allow testing of medications during pregnancy in the future. The ethical concerns surrounding the exposure of pregnant women to potential teratogens remain a significant barrier. Current efforts focus on improving post-marketing surveillance and encouraging the reporting of adverse effects to gather more data.
Choice C Reason:
Although some women may be reluctant to admit taking medications during pregnancy, this is not the primary reason for the lack of data on teratogenic effects. The main issue is the ethical and practical challenges of conducting clinical trials in pregnant women. Reluctance to report medication use can contribute to underreporting, but it is not the central factor.
Choice D Reason:
Recommending that pregnant women avoid medications is a general precaution, but it does not address the reason why more is not known about teratogenic effects. The avoidance of medications is advised to minimize potential risks, but the lack of data is primarily due to the ethical constraints of conducting clinical trials in this population.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Choice A: Alpha 1 Agonist and Alpha 2 Antagonist Increase Blood Pressure
Alpha 1 receptors are primarily located on the smooth muscles of blood vessels. When activated by an agonist, these receptors cause vasoconstriction, which increases blood pressure. On the other hand, alpha 2 receptors are found on presynaptic nerve terminals and act to inhibit the release of norepinephrine. An antagonist at alpha 2 receptors would prevent this inhibition, leading to increased norepinephrine release, further promoting vasoconstriction and increasing blood pressure. Therefore, the combination of an alpha 1 agonist and an alpha 2 antagonist would synergistically increase blood pressure.
Choice B: Alpha 1 Agonist and Alpha 2 Agonist Decrease Blood Pressure
Alpha 1 agonists increase blood pressure by causing vasoconstriction. Alpha 2 agonists, however, decrease blood pressure by inhibiting norepinephrine release, leading to vasodilation. Therefore, this combination would not decrease blood pressure as the effects of the alpha 1 agonist would counteract the effects of the alpha 2 agonist.
Choice C: Alpha 1 and Alpha 2 Agonist Increase Blood Pressure
While alpha 1 agonists increase blood pressure through vasoconstriction, alpha 2 agonists actually decrease blood pressure by reducing norepinephrine release. Therefore, this statement is incorrect as the combined effect would not result in an increase in blood pressure.
Choice D: Alpha 1 Antagonist and Alpha 2 Agonist Decrease Blood Pressure
Alpha 1 antagonists block the vasoconstrictive action of alpha 1 receptors, leading to vasodilation and a decrease in blood pressure. Alpha 2 agonists also decrease blood pressure by inhibiting norepinephrine release. Therefore, this combination would indeed decrease blood pressure, making this statement partially correct but not the best answer compared to choice A.
Correct Answer is B
Explanation
Choice A Reason:
Increased neuromuscular excitability is not typically associated with respiratory acidosis. Instead, respiratory acidosis can lead to symptoms such as confusion, fatigue, and shortness of breath due to the buildup of carbon dioxide in the blood. Neuromuscular excitability is more commonly associated with conditions like hypocalcemia.
Choice B Reason:
This is the correct answer. Respiratory acidosis occurs when the lungs cannot remove enough carbon dioxide (CO2) from the body, leading to an accumulation of CO2 in the blood. This increase in CO2 results in the formation of carbonic acid, which lowers the pH of the blood. The elevated levels of carbonic acid are a hallmark of respiratory acidosis.
Choice C Reason:
Increased pH is not associated with respiratory acidosis. In fact, respiratory acidosis is characterized by a decrease in blood pH due to the accumulation of carbon dioxide and the subsequent increase in carbonic acid. Therefore, this choice is incorrect.
Choice D Reason:
Hypokalemia, or low potassium levels, is not typically associated with respiratory acidosis. Instead, respiratory acidosis can sometimes lead to hyperkalemia (high potassium levels) due to the shift of potassium out of cells in response to the acidotic state. Therefore, this choice is incorrect.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today